Immunoassays for proteins alkylated by nicotine-derived N-nitrosamines
Polyclonal antibodies recognizing the pyridyloxobutyl (POB) moiety of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) were produced in rabbits immunized either with POB-bovine albumin or POB-Sepharose. The POB intermediates necessary to modify the protein were generated by alkaline (pH 9.0) treatment of the synthetic precursor 4-(carbethoxynitrosamino)-1-(3-pyridyl)-1-butanone. In a competitive enzyme linked immunoabsorbent assay (ELISA), 70 pmole NNK inhibited 50% of the binding of the anti-POB antibodies to POB-protein absorbed on microtiterplates. This 50% inhibition varied from 70 pmole to 200 nmole using a series of NNK analogues, depending on the integrity of the POB moiety. Immunological techniques initiated in this study detect NNK-protein conjugates or measure the quantity of POB groups liberated upon alkaline or acid treatment of NNK modified protein.
Key wordsCarcinogen-protein adducts Tobacco-specific N-nitrosamines Dosimeter of carcinogen exposure Immunoassay
Enzyme linked immunosorbent assay
Sodium dodecyl sulfate
phosphate buffered saline
Unable to display preview. Download preview PDF.
- Hecht SS, Chen CB, Dong M, Ornaf RM, Hoffmann D, Tso TC (1977) Studies on non-volatile nitrosamines in tobacco. Beitr Tabakforsh 9, 1–6Google Scholar
- Hoffmann D, Schmeltz I, Hecht SS, Wynder EL (1978) Tobacco carcinogenesis. In: Gelboin HV, Ts'o PO (eds) Polycyclic hydrocarbons and cancer, Vol. 1. Academic Press Inc., New York, pp 85–117Google Scholar
- US Department of Health and Human Services (1982) Smoking and Health. A report of the Surgeon General. DHEW, Washington, D.C., p. viGoogle Scholar